Sign in
770 CHARACTERIZATION OF THE HEPATOSELECTIVE DISTRIBUTION OF ACH-1625, A POTENT, CLINICAL STAGE HCV NS3 PROTEASE INHIBITOR
Journal article   Peer reviewed

770 CHARACTERIZATION OF THE HEPATOSELECTIVE DISTRIBUTION OF ACH-1625, A POTENT, CLINICAL STAGE HCV NS3 PROTEASE INHIBITOR

K. Stauber, C.W. Marlor, G. Mushtaq, V. Gadhachanda, G. Pais, A. Hashimoto, A. Phadke, M. Huang and M. Deshpande
Journal of hepatology, Vol.52, pp.S299-S299
2010

Metrics

1 Record Views

Details